- Home
- NTIP vs LVTX Comparison
NTIP vs LVTX Comparison
Compare NTIP & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIP
- LVTX
- Stock Information
- Founded
- NTIP 1990
- LVTX 2016
- Country
- NTIP United States
- LVTX Netherlands
- Employees
- NTIP N/A
- LVTX N/A
- Industry
- NTIP Multi-Sector Companies
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- NTIP Miscellaneous
- LVTX Health Care
- Exchange
- NTIP Nasdaq
- LVTX Nasdaq
- Market Cap
- NTIP 31.9M
- LVTX 33.1M
- IPO Year
- NTIP 1998
- LVTX 2021
- Fundamental
- Price
- NTIP $1.25
- LVTX $1.31
- Analyst Decision
- NTIP
- LVTX Hold
- Analyst Count
- NTIP 0
- LVTX 3
- Target Price
- NTIP N/A
- LVTX $1.75
- AVG Volume (30 Days)
- NTIP 6.5K
- LVTX 50.0K
- Earning Date
- NTIP 05-09-2025
- LVTX 05-14-2025
- Dividend Yield
- NTIP 8.00%
- LVTX N/A
- EPS Growth
- NTIP N/A
- LVTX N/A
- EPS
- NTIP N/A
- LVTX N/A
- Revenue
- NTIP $250,000.00
- LVTX $4,990,000.00
- Revenue This Year
- NTIP N/A
- LVTX N/A
- Revenue Next Year
- NTIP N/A
- LVTX N/A
- P/E Ratio
- NTIP N/A
- LVTX N/A
- Revenue Growth
- NTIP N/A
- LVTX N/A
- 52 Week Low
- NTIP $1.17
- LVTX $0.85
- 52 Week High
- NTIP $1.86
- LVTX $2.53
- Technical
- Relative Strength Index (RSI)
- NTIP 49.78
- LVTX 55.03
- Support Level
- NTIP $1.22
- LVTX $1.21
- Resistance Level
- NTIP $1.30
- LVTX $1.34
- Average True Range (ATR)
- NTIP 0.04
- LVTX 0.07
- MACD
- NTIP 0.00
- LVTX 0.00
- Stochastic Oscillator
- NTIP 50.00
- LVTX 81.25
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.